Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
7/13/2026
Updated
7/14/26, 3:04 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership